{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:12:00Z","timestamp":1760955120338},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"830","license":[{"start":{"date-parts":[[1994,12,1]],"date-time":"1994-12-01T00:00:00Z","timestamp":786240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1994,12,1]]},"DOI":"10.1136\/pgmj.70.830.860","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:25:21Z","timestamp":1230585921000},"page":"860-862","source":"Crossref","is-referenced-by-count":10,"title":["Thalidomide\u2014the way forward"],"prefix":"10.1093","volume":"70","author":[{"given":"J M","family":"Gardner-Medwin","sequence":"first","affiliation":[{"name":"Clinical Immunology Unit, Department of Immunology, University Hospital, Queen's Medical Centre , Nottingham NG7 2UH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"Powell","sequence":"additional","affiliation":[{"name":"Clinical Immunology Unit, Department of Immunology, University Hospital, Queen's Medical Centre , Nottingham NG7 2UH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1994,12,1]]},"reference":[{"issue":"57-61","key":"ref_1","first-page":"426","article-title":"Clinical experience with a new sedative drug","volume":"183","author":"Burley, D.M.; Dennison, T.C.; Harrison, W.","unstructured":"Burley, D.M., Dennison, T.C. & Harrison, W. Clinical experience with a new sedative drug. Practitioner 1959, 183: 57-61. 2 Kunz, W., Keller, H. & Mucher, N. N-Phtalyl-glutamisaureimid (N-phtalyl-glutamic imide). Arzneim Forsch Drug Res 1956, 6: 426-430.","journal-title":"Practitioner; N-Phtalyl-glutamisaureimid (N-phtalyl-glutamic imide). Arzneim Forsch Drug"},{"issue":"81","key":"ref_2","first-page":"2048","article-title":"Totale phokomelie","volume":"1959","author":"Weidenbach, A.","unstructured":"Weidenbach, A. Totale phokomelie. Zbl Gynak 1959, 81: 2048-2052.","journal-title":"Zbl Gynak"},{"issue":"2","key":"ref_3","first-page":"1358","article-title":"Thalidomide and congenital abnormalities (letter)","volume":"1961","author":"McBride, W.G.","unstructured":"McBride, W.G. Thalidomide and congenital abnormalities (letter). Lancet 1961, 2: 1358.","journal-title":"Lancet"},{"issue":"1","key":"ref_4","first-page":"45","article-title":"Thalidomide and congenital abnormalities (letter)","volume":"1962","author":"Lenz, W.","unstructured":"Lenz, W. Thalidomide and congenital abnormalities (letter). Lancet 1962, 1: 45.","journal-title":"Lancet"},{"issue":"267","key":"ref_5","first-page":"1238","article-title":"Medical progress: the saga of thalidomide (concluded). Neuropathy to embryopathy, with case reports of congenital anomalies","volume":"1962","author":"Mellin, G.W.; Katzenstein, M.","unstructured":"Mellin, G.W. & Katzenstein, M. Medical progress: the saga of thalidomide (concluded). Neuropathy to embryopathy, with case reports of congenital anomalies. N Engl J Med 1962, 267: 1238-1245.","journal-title":"N Engl J Med"},{"issue":"87","key":"ref_6","first-page":"1232","volume":"1962","author":"Lenz, W.; Knapp, K.","unstructured":"Lenz, W. & Knapp, K. Die Thalidomid-Embryopathie. Deutsche med Wchnschr 1962, 87: 1232.","journal-title":"Die Thalidomid-Embryopathie. Deutsche med Wchnschr"},{"issue":"1","key":"ref_7","first-page":"130","article-title":"Is thalidomide to blame?","volume":"1961","author":"Burley, D.","unstructured":"Burley, D. Is thalidomide to blame? Br Med J 1961, 1: 130.","journal-title":"Br Med J"},{"key":"ref_8","first-page":"2","article-title":"Is thalidomide to blame?","volume":"1960","author":"Florence, A.L.","year":"1954","unstructured":"Florence, A.L. Is thalidomide to blame? Br Med J 1960, 2: 1954. l0.,Kussenberg, E.V., Simpson, J.A. & Stanton, J.B. Is thalidomide to blame? Br Med J 1961, 1: 291.","journal-title":"Br Med J; Is thalidomide to blame"},{"key":"ref_9","first-page":"2","article-title":"Neuropathy after intake of thalidomide (Distaval)","volume":"1961","author":"Fullerton, P.M.; Kremer, M.","unstructured":"Fullerton, P.M. & Kremer, M. Neuropathy after intake of thalidomide (Distaval). Br Med J 1961, 2: 855-858.","journal-title":"Br Med J"},{"issue":"6","key":"ref_10","first-page":"303","article-title":"Thalidomide in the treatment of lepra reactions","volume":"1965","author":"Sheskin, J.","unstructured":"Sheskin, J. Thalidomide in the treatment of lepra reactions. Clin Pharmacol Therap 1965, 6: 303-306.","journal-title":"Clin Pharmacol Therap"},{"issue":"36","key":"ref_11","first-page":"183","article-title":"Further observations with thalidomide in lepra reactions","volume":"1965","author":"Sheskin, J.","unstructured":"Sheskin, J. Further observations with thalidomide in lepra reactions. Lepr Rev 1965, 36: 183-187.","journal-title":"Lepr Rev"},{"key":"ref_12","first-page":"1","article-title":"Therapeutische Erfa hrungen uber den Einfluss des Thalidomids bei der Lepra Reaktion","volume":"26","author":"Sheskin, J.","year":"1975","unstructured":"Sheskin, J. Therapeutische Erfa hrungen uber den Einfluss des Thalidomids bei der Lepra Reaktion. Hantarzt 1975, 26: 1-5.","journal-title":"Hantarzt"},{"issue":"12","key":"ref_13","first-page":"85","article-title":"Significant response of oral apthosis to thalidomide treatment","volume":"1985","author":"Grinspan, D.","unstructured":"Grinspan, D. Significant response of oral apthosis to thalidomide treatment. JAm AcadDermatol 1985, 12:85-90.","journal-title":"JAm AcadDermatol"},{"key":"ref_14","article-title":"Investigation of patients with orogenital ulceration responding to thalidomide","volume-title":"Recent Advances in Behfets Disease. Royal Society of Medicine Services","author":"Jenkins, J.S.; Powell, R.J.; Allen, B.R.; Littlewood, S.; Maurice, P.D.L.; Smith, N.J.","year":"1986","unstructured":"Jenkins, J.S., Powell, R.J., Allen, B.R., Littlewood, S., Maurice, P.D.L. & Smith, N.J. Investigation of patients with orogenital ulceration responding to thalidomide. In: Lehner, T. & Barnes, C.G. (eds) Recent Advances in Behfets Disease. Royal Society of Medicine Services, London, New York, 1986."},{"issue":"113","key":"ref_15","first-page":"141","article-title":"Investigation and treatment oforogenital ulceration; studies on a possible mode of action of thalidomide","volume":"1985","author":"Powell, R.J.; Allen, B.R.; Jenkins, J.S.","unstructured":"Powell, R.J., Allen, B.R., Jenkins, J.S. et al. Investigation and treatment oforogenital ulceration; studies on a possible mode of action of thalidomide. Br J Dermatol 1985, 113: 141 - 144.","journal-title":"Br J Dermatol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/bmj.287.6395.799","article-title":"Effect of thalidomide on orogenital ulceration","volume":"287","author":"Bowers, P.W.; Powell, R.J.","year":"1983","unstructured":"Bowers, P.W. & Powell, R.J. Effect of thalidomide on orogenital ulceration. Br Med J 1983, 287: 799-800.","journal-title":"Br Med J"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archderm.1982.01650200004003","article-title":"Thalidomide in the treatment of Behqet's syndrome","volume":"118","author":"Soylan, T.; Saltik, I.","year":"1982","unstructured":"Soylan, T. & Saltik, I. Thalidomide in the treatment of Behqet's syndrome. Arch Dermatol 1982, 118: 536.","journal-title":"Arch Dermatol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.1979.04010050060027","article-title":"Thalidomide in the treatment of recurrent, necrotic and giant mucocutaneous apthae and apthosis","volume":"115","author":"Mascaro, J.M.; Lecha, M.; Torras, H.","year":"1979","unstructured":"Mascaro, J.M., Lecha, M. & Torras, H. Thalidomide in the treatment of recurrent, necrotic and giant mucocutaneous apthae and apthosis. Arch Dermatol 1979, 115: 636-637.","journal-title":"Arch Dermatol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2796.1990.tb00253.x","article-title":"Case report treatment of severe colitis in Beh~et's syndrome with thalidomide (CG-217)","volume":"228","author":"Larsson, H.","year":"1990","unstructured":"Larsson, H. Case report treatment of severe colitis in Beh~et's syndrome with thalidomide (CG-217). J Intern Med 1990, 228: 405-407.","journal-title":"J Intern Med"},{"key":"ref_20","first-page":"326","article-title":"Thalidomide in the treatment of actinic prurigo","volume":"12","author":"Londono, F.","year":"1973","unstructured":"Londono, F. Thalidomide in the treatment of actinic prurigo. Int J Rheumatol 1973, 12: 326.","journal-title":"Int J Rheumatol"},{"key":"ref_21","first-page":"26","article-title":"Prurigo solar de altiplanicie","volume":"19","author":"Flores, 0","year":"1975","unstructured":"Flores, 0. Prurigo solar de altiplanicie. Dermatologia Rev Mex 1975, 19: 26.","journal-title":"Dermatologia Rev Mex"},{"key":"ref_22","first-page":"515","article-title":"La thalidomide dans le traitement du lupus erythemateux chronique","volume":"107","author":"Sammsoen, M.; Grosshans, E.; Basset, A.","year":"1980","unstructured":"Sammsoen, M., Grosshans, E. & Basset, A. La thalidomide dans le traitement du lupus erythemateux chronique. Ann Dermatol Venereol 1980, 107: 515-523."},{"key":"ref_23","first-page":"471","article-title":"Attivita e meccanismo d'azione della talidomide in 18 pazienti affetti da lupus eritemastoso discoide fisso","volume":"115","author":"Levi, L.; Saggiorato, F.; Crippa, D.","year":"1980","unstructured":"Levi, L., Saggiorato, F. & Crippa, D. Attivita e meccanismo d'azione della talidomide in 18 pazienti affetti da lupus eritemastoso discoide fisso. Giorn Ital Dermatol Vener 1980, 115: 471-475.","journal-title":"Giorn Ital Dermatol Vener"},{"key":"ref_24","first-page":"71","article-title":"Prurigo nodular de hyde tratado com talidomide","volume":"32","author":"Mattos, 0","year":"1973","unstructured":"Mattos, 0. Prurigo nodular de hyde tratado com talidomide. Biol Div Nac Lepra 1973, 32: 71-77.","journal-title":"Biol Div Nac Lepra"},{"key":"ref_25","first-page":"792","article-title":"Treatment of ulcerative colitis with thalidomide","volume":"123","author":"Waters, M.F.R.; Liang, A.B.G.; Amikapathy, A.; LennardJones, J.E.","year":"1979","unstructured":"Waters, M.F.R., Liang, A.B.G., Amikapathy, A. & LennardJones, J.E. Treatment of ulcerative colitis with thalidomide. Br Med J 1979, 123: 792.","journal-title":"Br Med J"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/0001555562449450","article-title":"Thalidomide treatment of reccurrent erythema multiforme","volume":"62","author":"Bakmer, F.A.; Zaur, H.; Luszpinski, P.","year":"1982","unstructured":"Bakmer, F.A., Zaur, H. & Luszpinski, P. Thalidomide treatment of reccurrent erythema multiforme. Acta Derm Venereol 1982, 62: 449.","journal-title":"Acta Derm Venereol"},{"key":"ref_27","first-page":"67","article-title":"Pyoderma Gangrenosum chez un enfant traitement par la thalidomide","volume":"29","author":"Venencie, P.Y.; Saurat, J.H.","year":"1982","unstructured":"Venencie, P.Y. & Saurat, J.H. Pyoderma Gangrenosum chez un enfant traitement par la thalidomide. Ann Pediatr (Paris) 1982, 29: 67-69.","journal-title":"Ann Pediatr (Paris)"},{"key":"ref_28","first-page":"317","article-title":"Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions","volume":"7","author":"Barnhill, R.L.; McDougall, A.C.","year":"1982","unstructured":"Barnhill, R.L. & McDougall, A.C. Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. JAm AcadDermatol 1982, 7: 317."},{"key":"ref_29","first-page":"251","article-title":"Thalidomide in Weber-Christian disease","volume":"1","author":"Evavelly, J.; Waters, M.F.R.","year":"1977","unstructured":"Evavelly, J. & Waters, M.F.R. Thalidomide in Weber-Christian disease. Lancet 1977, 1: 251.","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2141.1991.tb04377.x","article-title":"Thalidomide treatment for chronic graft-versus-host disease","volume":"78","author":"Heney, D.; Norfolk, D.R.; Wheeldon, J.; Bailey, C.C.; Lewis, I.J.; Barnard, D.L.","year":"1991","unstructured":"Heney, D., Norfolk, D.R., Wheeldon, J., Bailey, C.C., Lewis, I.J. & Barnard, D.L. Thalidomide treatment for chronic graft-versus-host disease. Br J Haematol 1991, 78: 23-27.","journal-title":"Br J Haematol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00007890-199001000-00005","article-title":"Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine","volume":"49","author":"Tamura, F.; Vogelsang, G.B.; Reitz, B.A.; Baumgartner, W.A.; Herskowitz, A.","year":"1990","unstructured":"Tamura, F., Vogelsang, G.B., Reitz, B.A., Baumgartner, W.A. & Herskowitz, A. Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine. Transplantation 1990, 49: 20-25.","journal-title":"Transplantation"},{"issue":"2","key":"ref_32","first-page":"1317","article-title":"Thalidomide forchronic graft-versus-host disease in children","volume":"1988","author":"Heney, D.; Lewis, I.J.; Bailey, C.C.","unstructured":"Heney, D., Lewis, I.J. & Bailey, C.C. Thalidomide forchronic graft-versus-host disease in children. Lancet 1988, 2: 1317.","journal-title":"Lancet"},{"issue":"2","key":"ref_33","first-page":"1135","article-title":"Thalidomide for graft versus host disease","volume":"1988","author":"McCarthy, D.M.; Kanfer, J.; Taylor, E.; Barrett, A.J.","unstructured":"McCarthy, D.M., Kanfer, J., Taylor, E. & Barrett, A.J. Thalidomide for graft versus host disease. Lancet 1988, 2: 1135.","journal-title":"Lancet"},{"issue":"1","key":"ref_34","first-page":"827","article-title":"Thalidomide for graft-versus-host disease","volume":"1988","author":"Vogelsang, G.B.; Santos, G.W.; Colvin, O.M.; Chen, T.","unstructured":"Vogelsang, G.B., Santos, G.W., Colvin, O.M. & Chen, T. Thalidomide for graft-versus-host disease. Lancet 1988, 1: 827.","journal-title":"Lancet"},{"key":"ref_35","first-page":"424","article-title":"Apthous ulcers in HIV-infected patients: treatment with thalidomide","volume":"68","author":"Strazi, S.; Lebbe, C.; Geoggray, C.; Ablon, G.; Morel, P.","year":"1992","unstructured":"Strazi, S., Lebbe, C., Geoggray, C., Ablon, G. & Morel, P. Apthous ulcers in HIV-infected patients: treatment with thalidomide. Genitourin Med 1992, 68: 424-425.","journal-title":"Genitourin Med"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJM199207163270319","article-title":"Thalidomide to treat oesophageal ulcers in AIDS","volume":"327","author":"Ryan, J.; Coleman, J.; Pedersen, J.; Benson, E.","year":"1992","unstructured":"Ryan, J., Coleman, J., Pedersen, J. & Benson, E. Thalidomide to treat oesophageal ulcers in AIDS. NEngl J Med 1992, 327: 208-209.","journal-title":"NEngl J Med"},{"key":"ref_37","first-page":"432","article-title":"Treatment of resistant apthous ulceration with thalidomide in patients positive for HIV antibody","volume":"298","author":"Youle, M.; Clabour, J.; Farthing, C.","year":"1989","unstructured":"Youle, M., Clabour, J., Farthing, C. et al. Treatment of resistant apthous ulceration with thalidomide in patients positive for HIV antibody. Br Med J 1989, 298: 432. Makonkawkeyoon, S., Limson-Probre, R.N., Moreira, A.L., Schauf, V. & Kaplan, G. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Nadl Acad Sci USA 1993, 90: 5974-5978.","journal-title":"Br Med J; virus type 1. Proc Nadl Acad Sci USA; Thalidomide inhibits the replication of human immunodeficiency"},{"key":"ref_38","article-title":"The Medicines Act 1968","year":"1968","unstructured":"The Medicines Act 1968. HMSO, London, 1968."},{"key":"ref_39","first-page":"1057","article-title":"Thalidomide for SLE","author":"Hawkins, D.F.","year":"1993","unstructured":"Hawkins, D.F. Thalidomide for SLE. Lancet 1993,339:1057.","journal-title":"Lancet"},{"issue":"251","key":"ref_40","first-page":"3208","article-title":"More cautionary labeling appears on isotretinoin","volume":"1984","author":"Marwick, C.","unstructured":"Marwick, C. More cautionary labeling appears on isotretinoin. JAMA 1984, 251: 3208-3209.","journal-title":"JAMA"},{"key":"ref_41","article-title":"Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behqet's disease: the use of neurophysiological studies to detect thalidomide neuropathy","volume":"53","author":"Gardner-Medwin, J.M.; Powell, R.J.","year":"1994","unstructured":"Gardner-Medwin, J.M. & Powell, R.J. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behqet's disease: the use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis 1994, 53 (in press).","journal-title":"Ann Rheum Dis"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/70\/830\/860\/50218077\/postgradmedj-70-860.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/70\/830\/860\/50218077\/postgradmedj-70-860.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T03:28:49Z","timestamp":1709868529000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/70\/830\/860\/7059432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,12,1]]},"references-count":41,"journal-issue":{"issue":"830","published-online":{"date-parts":[[1994,12,1]]},"published-print":{"date-parts":[[1994,12,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.70.830.860","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1994,12]]},"published":{"date-parts":[[1994,12,1]]}}}